Enhanced IVD Biomaterials to increase Immunoassay Robustness
Facing the challenge to increase robustness and yield of an IVD Biomaterial manufacturing process in industrial scale
When optimizing the manufacturing process of a key raw material used in a commercial immunoassay, product specifications and biomaterial performance must remain the same.
In that context, incorporating new technologies both upstream and downstream let us increase the productivity of the processes. Moreover, to increase the chances of success in challenging projects while reducing time to market, state-of-the-art equipment such as high throughput screening is used.
Join us in our next webinar Enhanced IVD Biomaterials to increase Immunoassay Robustness the March 2nd, 2021, to hear more details about this success story. There will be 2 sessions:
- 9AM (GMT+1) / 4PM (GMT+8) / 5PM (GMT+9)
- 5PM (GMT+1) / 11AM (GMT-5) / 8AM (GMT-8)
Note: The Session will be subtitled in english, japanese or chinese